Pfizer, Inc. (PFE) Tops Q1 EPS by 2c; Cuts FY12 Outlook
Tweet Send to a Friend
Get Alerts PFE Hot Sheet
Price: $29.11 --0%
Revenue Growth %: -12.3%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: -12.3%
Financial Fact:
Discontinued operations--net of tax (in dollars per share): 0
Today's EPS Names:
ANF, DXLG, FL, More
Trade PFE Now!
Pfizer, Inc. (NYSE: PFE) reported Q1 EPS of $0.58, $0.02 better than the analyst estimate of $0.56. Revenue for the quarter came in at $15.4 billion versus the consensus estimate of $15.47 billion.
Sees FY12 adj-EPS of $2.14-$2.24 on sales of $58-$60 billion. The Street is currently expecting FY12 EPS of $2.26 on sales of $62.14 billion. Pfizer had previously guided FY12 adj-EPS to $2.20-$2.30 on sales of $60.5-$62.5 billion.
For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Sees FY12 adj-EPS of $2.14-$2.24 on sales of $58-$60 billion. The Street is currently expecting FY12 EPS of $2.26 on sales of $62.14 billion. Pfizer had previously guided FY12 adj-EPS to $2.20-$2.30 on sales of $60.5-$62.5 billion.
For earnings history and earnings-related data on Pfizer, Inc. (PFE) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- GameStop Corp. (GME) Tops Q1 EPS by 6c; Boosts Lower-End of FY13 EPS Outlook
- Gap, Inc. (GPS) Tops Q1 EPS by 2c; Reaffirms Outlook
Create E-mail Alert Related Categories
Earnings, Guidance, Hot Guidance, Hot ListRelated Entities
EarningsLogin with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

